title: Sarbanes-Oxley overburdens biotech companies.
authors.forename: Mark
authors.initials: M
authors.lastname: Kessel
mesh_terms: D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D007449:Investments; D058012:Small Business